BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonomi M, De Filippis C, Lopci E, Gianoncelli L, Rizzardi G, Cerchiaro E, Bortolotti L, Zanello A, Ceresoli GL. Clinical staging of malignant pleural mesothelioma: current perspectives. Lung Cancer (Auckl) 2017;8:127-39. [PMID: 28860886 DOI: 10.2147/LCTT.S102113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Cameron RB. Staging in the era of international databases: documented improvements with remaining challenges. J Thorac Dis 2018;10:682-7. [PMID: 29607134 DOI: 10.21037/jtd.2018.01.23] [Reference Citation Analysis]
2 Idkedek M, Tahayneh KS, Abu-akar F, Bakri IA. Case Report and Review of Literature: Familial Malignant Pleural Mesothelioma in a 39 Years Old Patient With an Inconclusive 18F-FDG PET/CT Result. Front Surg 2022;9:819596. [DOI: 10.3389/fsurg.2022.819596] [Reference Citation Analysis]
3 Brown LB, Corl F, Blackmon SH. Surgical staging and resection of malignant pleural mesothelioma. J Thorac Dis 2020;12:7467-80. [PMID: 33447434 DOI: 10.21037/jtd-19-2267] [Reference Citation Analysis]
4 Arrieta O, Escamilla-López I, Lyra-González I, Barrón F, Ramírez-Tirado LA, Vergara E, Corona-Cruz JF, Maldonado F, Jiménez-Fuentes E. Radical aggressive treatment among non-small cell lung cancer patients with malignant pleural effusion without extra-thoracic disease. J Thorac Dis 2019;11:595-601. [PMID: 30963004 DOI: 10.21037/jtd.2019.01.36] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Usuda K, Iwai S, Funasaki A, Sekimura A, Motono N, Matoba M, Doai M, Yamada S, Ueda Y, Uramoto H. Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural Diseases. Cancers (Basel) 2019;11:E811. [PMID: 31212757 DOI: 10.3390/cancers11060811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Muralidhar V, Raghav P, Das P, Goel A. A case from India of pleural malignant mesothelioma probably due to domestic and environmental asbestos exposure: a posthumous report. BMJ Case Rep 2019;12:e227882. [PMID: 30936339 DOI: 10.1136/bcr-2018-227882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
7 Ahmadzada T, Cooper WA, Holmes M, Mahar A, Westman H, Gill AJ, Nordman I, Yip PY, Pal A, Zielinski R, Pavlakis N, Nagrial A, Daneshvar D, Brungs D, Karikios D, Aleksova V, Burn J, Asher R, Grau GE, Hosseini-Beheshti E, Reid G, Clarke S, Kao S. Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population. JTO Clin Res Rep 2020;1:100075. [PMID: 34589956 DOI: 10.1016/j.jtocrr.2020.100075] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]